Holen Sie sich die Stockscreener-App
1.09
21.10%
0.1899
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - marketwatch.com
HC Wainwright Issues Negative Estimate for INO Earnings - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Strong-Buy at Zacks Research - MarketBeat
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
INO Upgraded by Jefferies -- Price Target Raised to $3.00 - GuruFocus
Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target By Investing.com - Investing.com Canada
Inovio Q2 2026 slides: INO-3107 on track for Oct FDA decision - Investing.com Nigeria
Jefferies upgrades Inovio stock rating on FDA review progress By Investing.com - Investing.com Canada
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO): What Does the Latest Update Mean for Regulatory Progress? - Kalkine Media
Inovio Pharmaceuticals Inc (INO) (Q2 2026) Earnings Call Highlights: INO-3107 on Track for ... - Yahoo Finance
Inovio Pharmaceuticals Inc (INO) (Q2 2026) Earnings Call Highlig - GuruFocus
Inovio Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Inovio Pharmaceuticals, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:INO) 2026-08-12 - Seeking Alpha
Inovio (INO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
Inovio Q2 EPS $(0.07) beats $(0.22) estimate; loss narrows 74% - scanx.trade
Inovio Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Earnings call transcript: Inovio narrows Q2 2026 loss as INO-3107 nears FDA date - Investing.com
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Inovio: Q2 Earnings Snapshot - marketscreener.com
BRIEF-Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million - TradingView
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights - PR Newswire
Adage Capital (INO) discloses 3.43M Inovio shares via warrants in 13G/A - Stock Titan
Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri - AOL.com
Inovio Pharmaceuticals (NASDAQ:INO): What Could Today’s pipeline focus and funding discipline Update Reveal? - Kalkine Media
Inovio Pharmaceuticals Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Inovio Pharmaceuticals Inc Annual Shareholders Meeting Transcript - GuruFocus
Q1 2026 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
RA Capital reports 10.67M-share Inovio (NASDAQ: INO) stake capped at 9.99% - Stock Titan
Inovio Pharmaceuticals, Inc. Share Price Live Today – NASDAQ:INO Stock Price, Chart, News, History - Upstox
Inovio Pharmaceuticals (INO.US) will release its earnings report after market close on August 12. - Moomoo
FMR LLC (INO) discloses 8.45M Inovio shares, including major fund holder - Stock Titan
Inovio Pharmaceuticals (INO) Projected to Release Earnings on Wednesday - MarketBeat
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
INOVIO to Report Second Quarter Financial Results on August 12, 2026 - Moomoo
INO Reiterates by Piper Sandler -- Price Target Lowers to $4.00 - GuruFocus
Piper Sandler Reiterates "Overweight" Rating for Inovio Pharmaceuticals (NASDAQ:INO) - MarketBeat
Inovio Pharmaceuticals Inc : Piper Sandler Cu - moomoo.com
Inovio proposes underwritten public offering of common stock, warrants - Bitget
Vanguard Capital Management (INO) discloses 5.05% beneficial stake in Inovio stock - Stock Titan
Form 424B5 Inovio Pharmaceuticals Inc For: 30 July By Investing.com - Investing.com UK
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Stock Falls 21% After Hours: Here's What's Going On - Benzinga
Inovio prices $20M stock offering, its second raise in quick succession - Dealroom
Inovio prices $20 million public offering of stock and warrants By Investing.com - Investing.com South Africa
Inovio Announces Pricing of $20.0 Million Pub - moomoo.com
INOVIO Announces Proposed Public Offering - GuruFocus
Inovio announces proposed public offering of stock and warrants By Investing.com - Investing.com Nigeria
INO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
INOVIO Plans Stock and Warrant Sale, Size and Terms Unclear - Stock Titan
Inovio Pharmaceuticals Inc (INO) Institutional Confidence - TradingKey
INO|Inovio Pharmaceuticals Inc|Price:0.967|Chg%:-0.003 - TradingKey
Inovio Pharmaceuticals Inc (INO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inovio Pharmaceuticals Inc (INO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):